MiRNA analysis methods

US9637781B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9637781-B2
Application numberUS-201314378675-A
CountryUS
Kind codeB2
Filing dateFeb 13, 2013
Priority dateFeb 14, 2012
Publication dateMay 2, 2017
Grant dateMay 2, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention provides a PCR-free, multiplexed ligation assay for miRNA expression analysis that produces highly quantitative, 10-100 plex miRNA profiling in a single reaction. The inventive methods use a 2-step ligation assay to generate an array of miRNA specific ligation products that can be decoded and quantified by a size discrimination method such as gel electrophoresis or single molecule separation. One embodiment is a low-cost assay that can be performed using standard tools available in nearly all molecular biology laboratories. This assay requires nothing more than a gel apparatus and reader for detection. Other embodiments include use of magnetic beads and other size exclusion apparatus which give increasingly higher sensitivity, lower sample consumption, and reduced processing steps.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method for detection of one or more target miRNA of interest in a sample comprising: a) obtaining a sample containing one or more target miRNA of interest; b) adding to the sample of a) a sufficient amount of adapter probes and a sufficient amount of a first ligase c) performing a first ligation step by incubation and allowing the adapter probes to be ligated to the 3′-OH ends of the one or more target miRNA of interest in the sample; d) adding to the sample of b) a sufficient amount of common probes and discrimination probes, and a sufficient amount of a second ligase; e) performing a second ligation step by incubating the sample of c) for a sufficient amount of time to effect hybridization of the common probes and discrimination probes of d) with ligated one or more target miRNA of interest and adapter probes of b) and to allow ligation between the discrimination probes and common probes; and f) analysis of the hybridized and ligated common probes and discrimination probes of d) with the ligated one or more target miRNA of interest and adapter probes of b) by one or more size discrimination methods. 2. The method of claim 1 , wherein the adapter probe comprises 5-50 DNA nucleotides in length and is phosphorylated at the 5′ end. 3. The method of claim 2 , wherein the adapter probe is pre-adenylated at the 5′ end. 4. The method of claim 3 , wherein the adapter probe is blocked at the 3′ end with ddC or NH 2 . 5. The method of claim 1 , wherein the discrimination probes comprise a 5′ recognition sequence having a DNA oligonucleotide sequence complementary to the one or more target miRNA of interest and having a 3′ variable length coding sequence (VLCS) having at least 5 to about 200 nucleotides in length. 6. The method of claim 5 , wherein the VLCS length is specific to one or more target miRNAs of interest. 7. The method of claim 1 , wherein the common probe comprises a detectable label which is selected from the group consisting of fluorescent probes, near infra-red probes, FRET probes, luminescent probes and radionuclides. 8. The method of claim 1 , wherein in f) the size discrimination is performed using electrophoresis. 9. The method of claim 1 , wherein in f) the size discrimination is performed using single molecule free solution hydrodynamic separation (SML-FSHS). 10. The method of claim 1 , wherein in f) the size discrimination is performed using chromatography. 11. The method of claim 1 , wherein the incubation step e further comprises thermocycling the sample for 1-100 cycles by heating the sample for about 0.25 minutes to about 5 minutes at 45° C. to about 95° C. for denaturation and hybridization of the discrimination and common probes, followed by heating the sample for about 0.25 minutes to about 100 minutes at 4° C. to about 80° C. to complete ligation of the discrimination and common probes. 12. The method of claim 1 , wherein internal controls are added to account for variations in ligation efficiency. 13. The method of claim 1 , wherein the first ligase is selected from the group consisting of T4 RNA ligase 1, T4 RNA ligase 2 truncated, T4 RNA ligase 2 K227Q, T4 RNA ligase 2 truncated KQ, and Methanobacterium thermoautotrophicum RNA ligase. 14. The method of claim 1 , wherein the second ligase is selected from the group consisting of E. Coli DNA ligase, Taq DNA ligase, 9° N DNA ligase, T4 DNA ligase, T4 RNA ligase 2, and Ampligase. 15. The method of claim 1 , wherein the method further comprises PCR amplification of the reaction products comprising the hybridized and ligated common probes and discrimination probes of d) with the ligated one or more target miRNA of interest and adapter probes of b), is performed after the second ligation step but before size discrimination methods.

Assignees

Inventors

Classifications

  • in screening processes · CPC title

  • General methods applicable to biologically active non-coding nucleic acids · CPC title

  • involving enzymes not classifiable in groups C12Q1/26 {- C12Q1/66} · CPC title

  • C12Q1/6862Primary

    Ligase chain reaction [LCR] · CPC title

  • Hybridisation assays · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9637781B2 cover?
The present invention provides a PCR-free, multiplexed ligation assay for miRNA expression analysis that produces highly quantitative, 10-100 plex miRNA profiling in a single reaction. The inventive methods use a 2-step ligation assay to generate an array of miRNA specific ligation products that can be decoded and quantified by a size discrimination method such as gel electrophoresis or single …
Who is the assignee on this patent?
Univ Johns Hopkins
What technology area does this patent fall under?
Primary CPC classification C12Q1/6862. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue May 02 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).